Utility of screening for other causes of infertility in women with "known" polycystic ovary syndrome

Peter G. McGovern; Richard S. Legro; Evan R. Myers; Huiman X. Barnhart; Sandra A. Carson; Michael P. Diamond; Bruce R. Carr; William D. Schlaff; Christos Coutifaris; Michael P. Steinkampf; John E. Nestler; Gabey Gosman; Phyllis C. Leppert; Linda C. Giudice

doi:10.1016/j.fertnstert.2006.06.050

Utility of screening for other causes of infertility in women with "known" polycystic ovary syndrome

Peter G. McGovern, Richard S. Legro, Evan R. Myers, Huiman X. Barnhart, Sandra A. Carson, Michael P. Diamond, Bruce R. Carr, William D. Schlaff, Christos Coutifaris, Michael P. Steinkampf, John E. Nestler, Gabey Gosman, Phyllis C. Leppert, Linda C. Giudice

Obstetrics and Gynecology

Research output: Contribution to journal › Article

8 Scopus citations

Abstract

We investigated the prevalence of abnormal screening results (questionnaire and testing for other causes of oligo-ovulation, male or tubal factor infertility) in a group of 1,313 oligo-ovulatory women (included and excluded subjects) whose condition was screened for inclusion in the Pregnancy in Polycystic Ovary Syndrome trial, a multicenter clinical trial that was conducted at 13 sites in the United States. Other than failure to demonstrate laboratory evidence of hyperandrogenemia, the most common reasons for subject exclusion were persistent oligospermia and tubal factor infertility.

Original language	English (US)
Pages (from-to)	442-444
Number of pages	3
Journal	Fertility and sterility
Volume	87
Issue number	2
DOIs	https://doi.org/10.1016/j.fertnstert.2006.06.050
State	Published - Feb 2007

ASJC Scopus subject areas

Reproductive Medicine
Obstetrics and Gynecology

Access to Document

10.1016/j.fertnstert.2006.06.050

Fingerprint Dive into the research topics of 'Utility of screening for other causes of infertility in women with "known" polycystic ovary syndrome'. Together they form a unique fingerprint.

Cite this

McGovern, P. G., Legro, R. S., Myers, E. R., Barnhart, H. X., Carson, S. A., Diamond, M. P., Carr, B. R., Schlaff, W. D., Coutifaris, C., Steinkampf, M. P., Nestler, J. E., Gosman, G., Leppert, P. C., & Giudice, L. C. (2007). Utility of screening for other causes of infertility in women with "known" polycystic ovary syndrome. Fertility and sterility, 87(2), 442-444. https://doi.org/10.1016/j.fertnstert.2006.06.050

Utility of screening for other causes of infertility in women with "known" polycystic ovary syndrome. / McGovern, Peter G.; Legro, Richard S.; Myers, Evan R.; Barnhart, Huiman X.; Carson, Sandra A.; Diamond, Michael P.; Carr, Bruce R.; Schlaff, William D.; Coutifaris, Christos; Steinkampf, Michael P.; Nestler, John E.; Gosman, Gabey; Leppert, Phyllis C.; Giudice, Linda C.

In: Fertility and sterility, Vol. 87, No. 2, 02.2007, p. 442-444.

Research output: Contribution to journal › Article

McGovern, PG, Legro, RS, Myers, ER, Barnhart, HX, Carson, SA, Diamond, MP, Carr, BR, Schlaff, WD, Coutifaris, C, Steinkampf, MP, Nestler, JE, Gosman, G, Leppert, PC & Giudice, LC 2007, 'Utility of screening for other causes of infertility in women with "known" polycystic ovary syndrome', Fertility and sterility, vol. 87, no. 2, pp. 442-444. https://doi.org/10.1016/j.fertnstert.2006.06.050

McGovern, Peter G. ; Legro, Richard S. ; Myers, Evan R. ; Barnhart, Huiman X. ; Carson, Sandra A. ; Diamond, Michael P. ; Carr, Bruce R. ; Schlaff, William D. ; Coutifaris, Christos ; Steinkampf, Michael P. ; Nestler, John E. ; Gosman, Gabey ; Leppert, Phyllis C. ; Giudice, Linda C. / Utility of screening for other causes of infertility in women with "known" polycystic ovary syndrome. In: Fertility and sterility. 2007 ; Vol. 87, No. 2. pp. 442-444.

@article{dcea9a4ae90343dc8fe5a6cb941c6af6,

title = "Utility of screening for other causes of infertility in women with {"}known{"} polycystic ovary syndrome",

abstract = "We investigated the prevalence of abnormal screening results (questionnaire and testing for other causes of oligo-ovulation, male or tubal factor infertility) in a group of 1,313 oligo-ovulatory women (included and excluded subjects) whose condition was screened for inclusion in the Pregnancy in Polycystic Ovary Syndrome trial, a multicenter clinical trial that was conducted at 13 sites in the United States. Other than failure to demonstrate laboratory evidence of hyperandrogenemia, the most common reasons for subject exclusion were persistent oligospermia and tubal factor infertility.",

author = "McGovern, {Peter G.} and Legro, {Richard S.} and Myers, {Evan R.} and Barnhart, {Huiman X.} and Carson, {Sandra A.} and Diamond, {Michael P.} and Carr, {Bruce R.} and Schlaff, {William D.} and Christos Coutifaris and Steinkampf, {Michael P.} and Nestler, {John E.} and Gabey Gosman and Leppert, {Phyllis C.} and Giudice, {Linda C.}",

year = "2007",

month = feb,

doi = "10.1016/j.fertnstert.2006.06.050",

language = "English (US)",

volume = "87",

pages = "442--444",

journal = "Fertility and Sterility",

issn = "0015-0282",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Utility of screening for other causes of infertility in women with "known" polycystic ovary syndrome

AU - McGovern, Peter G.

AU - Legro, Richard S.

AU - Myers, Evan R.

AU - Barnhart, Huiman X.

AU - Carson, Sandra A.

AU - Diamond, Michael P.

AU - Carr, Bruce R.

AU - Schlaff, William D.

AU - Coutifaris, Christos

AU - Steinkampf, Michael P.

AU - Nestler, John E.

AU - Gosman, Gabey

AU - Leppert, Phyllis C.

AU - Giudice, Linda C.

PY - 2007/2

Y1 - 2007/2

N2 - We investigated the prevalence of abnormal screening results (questionnaire and testing for other causes of oligo-ovulation, male or tubal factor infertility) in a group of 1,313 oligo-ovulatory women (included and excluded subjects) whose condition was screened for inclusion in the Pregnancy in Polycystic Ovary Syndrome trial, a multicenter clinical trial that was conducted at 13 sites in the United States. Other than failure to demonstrate laboratory evidence of hyperandrogenemia, the most common reasons for subject exclusion were persistent oligospermia and tubal factor infertility.

AB - We investigated the prevalence of abnormal screening results (questionnaire and testing for other causes of oligo-ovulation, male or tubal factor infertility) in a group of 1,313 oligo-ovulatory women (included and excluded subjects) whose condition was screened for inclusion in the Pregnancy in Polycystic Ovary Syndrome trial, a multicenter clinical trial that was conducted at 13 sites in the United States. Other than failure to demonstrate laboratory evidence of hyperandrogenemia, the most common reasons for subject exclusion were persistent oligospermia and tubal factor infertility.

UR - http://www.scopus.com/inward/record.url?scp=33846588485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846588485&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2006.06.050

DO - 10.1016/j.fertnstert.2006.06.050

M3 - Article

C2 - 17141768

AN - SCOPUS:33846588485

VL - 87

SP - 442

EP - 444

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 2

ER -